Provided by Tiger Trade Technology Pte. Ltd.

Pharming Group N.V.

9.79
+0.26002.73%
Post-market: 9.790.00000.00%19:30 EDT
Volume:3K
Turnover:32.54K
Market Cap:691.42M
PE:77.36
High:9.85
Open:9.79
Low:9.52
Close:9.53
52wk High:21.34
52wk Low:9.44
Shares:70.63M
Float Shares:69.50M
Volume Ratio:0.43
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1266
EPS(LYR):0.0400
ROE:3.65%
ROA:3.47%
PB:2.56
PE(LYR):244.75

Loading ...

Press Release: Pharming Reports Second Quarter and First Half 2026 Financial Results and Revises Year-end Guidance; Strong Joenja Momentum and Near-term Clinical Readouts to Support Broader Therapeutic Use

Dow Jones
·
Jul 30

Pharming Group NV Expected to Post Earnings of 2 Cents a Share - Earnings Preview

Reuters
·
Jul 28

Pharming Group Says Marketing Application for Immunodeficiency Disorder Drug Accepted by FDA

MT Newswires Live
·
Jun 04

Pharming Says European Commission Grants Marketing Authorization to Joenja

MT Newswires Live
·
May 23

Pharming’s Joenja granted marketing authorization by European Commission

TIPRANKS
·
May 23

Pharming Group (PHAR) Gets a Buy from Canaccord Genuity

TIPRANKS
·
May 09

ADRs End Lower; Pharming Group N.V. Declines 27%

Dow Jones
·
May 08

Stock Track | Pharming Group Plunges 17.32% in Pre-Market After Q1 Earnings and Revenue Miss Estimates

Stock Track
·
May 07

Stock Track | Pharming Group Plunges 11.95% in Pre-market After Q1 Earnings Miss Estimates

Stock Track
·
May 07

Pharming Group NV reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

Pharming Q1 EPS $(0.07) Misses $0.01 Estimate, Sales $72.400M Miss $93.750M Estimate

Benzinga Earnings
·
May 07

Press Release: Pharming Group reports first quarter 2026 financial results; on track for Joenja(R) U.S. pediatric label expansion and launches in Japan and Europe in 2026

Dow Jones
·
May 07

Pharming Group NV expected to post earnings of 1 cent a share - Earnings Preview

Reuters
·
May 05

Earning Preview: Pharming Group N.V. Q1 revenue is expected to increase by 38.41%, and institutional views are predominantly bullish

Earnings Agent
·
Apr 30